PT94625A - Processo de preparacao de analogos de substituicao de peptidos magainina e de composicoes farmaceuticas que os contem - Google Patents

Processo de preparacao de analogos de substituicao de peptidos magainina e de composicoes farmaceuticas que os contem

Info

Publication number
PT94625A
PT94625A PT94625A PT9462590A PT94625A PT 94625 A PT94625 A PT 94625A PT 94625 A PT94625 A PT 94625A PT 9462590 A PT9462590 A PT 9462590A PT 94625 A PT94625 A PT 94625A
Authority
PT
Portugal
Prior art keywords
magainine
peptides
pharmaceutical compositions
preparing
analogs
Prior art date
Application number
PT94625A
Other languages
English (en)
Other versions
PT94625B (pt
Inventor
Richard A Houghten
Julio H Cuervo
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of PT94625A publication Critical patent/PT94625A/pt
Publication of PT94625B publication Critical patent/PT94625B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT94625A 1989-07-07 1990-07-06 Processo de preparacao de analogos de substituicao de peptidos magainina e de composicoes farmaceuticas que os contem PT94625B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37675489A 1989-07-07 1989-07-07

Publications (2)

Publication Number Publication Date
PT94625A true PT94625A (pt) 1991-03-20
PT94625B PT94625B (pt) 1997-03-31

Family

ID=23486335

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94625A PT94625B (pt) 1989-07-07 1990-07-06 Processo de preparacao de analogos de substituicao de peptidos magainina e de composicoes farmaceuticas que os contem

Country Status (16)

Country Link
EP (4) EP0751149A3 (pt)
JP (1) JP2854970B2 (pt)
CN (1) CN1055480C (pt)
AT (1) ATE146188T1 (pt)
AU (1) AU650236B2 (pt)
CA (1) CA2020663C (pt)
DE (1) DE69029377T2 (pt)
DK (1) DK0437556T3 (pt)
ES (1) ES2095255T3 (pt)
IE (1) IE63842B1 (pt)
IL (1) IL94939A (pt)
PH (4) PH30054A (pt)
PT (1) PT94625B (pt)
SG (1) SG47913A1 (pt)
WO (1) WO1991000869A1 (pt)
ZA (1) ZA905203B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG47913A1 (en) * 1989-07-07 1998-04-17 Scripps Research Inst Substitution analogues of magainin peptides
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
AU648140B2 (en) * 1991-02-01 1994-04-14 Virtual Drug Development, Inc. Reverse antimicrobial peptides and antimicrobial compositions
CA2111214A1 (en) * 1991-06-12 1992-12-23 W. Lee Maloy Composition and treatment with biologically active peptides having c-terminal substitutions
US5424290A (en) * 1992-10-26 1995-06-13 Magainin Pharmaceuticals Inc. Biologically active peptides and uses therefor
US5773413A (en) * 1993-06-04 1998-06-30 Demeter Biotechnologies, Ltd. Method of combating mammalian neoplasias, and lytic peptides therefor
US5561107A (en) * 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
CN101928340A (zh) * 2009-12-24 2010-12-29 深圳市圣西马生物技术有限公司 一组抗菌肽衍生物及其应用
CN104710523B (zh) * 2013-12-11 2017-12-29 华东理工大学 对铜绿假单胞菌具有抗菌性能的Magainin肽修饰物及其制备方法
BR112017028413A2 (pt) * 2015-07-02 2018-08-28 Dana Farber Cancer Inst Inc peptídeos antimicrobianos estabilizados
JP7105696B2 (ja) 2016-02-29 2022-07-25 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド
US11325955B2 (en) 2017-07-19 2022-05-10 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
CN111892646B (zh) * 2020-08-13 2023-05-02 中国人民解放军军事科学院军事医学研究院 抗菌肽衍生物及其在制备抗细菌感染药物中的应用
CN112625092B (zh) * 2021-01-13 2023-03-28 兰州大学 一种基于polybia-MPI的抗菌多肽化合物及其合成与应用
CN114634553B (zh) * 2022-04-27 2024-03-08 贵州医科大学 阳离子肽c9及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2515763B2 (ja) * 1986-11-17 1996-07-10 株式会社小松製作所 埋設物探査方法
EP0362209B1 (en) * 1987-03-04 1994-06-08 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce New synthetic bioactive compounds and method of producing bioactive effect
US4810777A (en) 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
SG47913A1 (en) * 1989-07-07 1998-04-17 Scripps Research Inst Substitution analogues of magainin peptides

Also Published As

Publication number Publication date
ATE146188T1 (de) 1996-12-15
ES2095255T3 (es) 1997-02-16
EP0437556A4 (en) 1992-05-20
EP0751148A2 (en) 1997-01-02
EP0761684A3 (en) 1997-07-02
EP0761684A2 (en) 1997-03-12
EP0437556A1 (en) 1991-07-24
JPH04506801A (ja) 1992-11-26
CA2020663C (en) 1999-12-07
WO1991000869A1 (en) 1991-01-24
DE69029377D1 (de) 1997-01-23
IE902476A1 (en) 1991-02-13
AU650236B2 (en) 1994-06-16
EP0437556B1 (en) 1996-12-11
PH30054A (en) 1996-11-08
PH30219A (en) 1997-02-05
EP0751148A3 (en) 1997-07-02
ZA905203B (en) 1991-05-29
CN1055480C (zh) 2000-08-16
DK0437556T3 (da) 1996-12-30
DE69029377T2 (de) 1997-06-19
CA2020663A1 (en) 1991-01-08
EP0751149A3 (en) 1997-07-02
PT94625B (pt) 1997-03-31
IL94939A0 (en) 1991-06-10
CN1049166A (zh) 1991-02-13
IL94939A (en) 1996-12-05
IE63842B1 (en) 1995-06-14
EP0751149A2 (en) 1997-01-02
AU5945490A (en) 1991-02-06
PH30410A (en) 1997-05-09
JP2854970B2 (ja) 1999-02-10
SG47913A1 (en) 1998-04-17
PH30218A (en) 1997-02-05

Similar Documents

Publication Publication Date Title
PT94625A (pt) Processo de preparacao de analogos de substituicao de peptidos magainina e de composicoes farmaceuticas que os contem
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
DK0469074T3 (da) Cystein-tilsatte varianter af IL-3 og kemiske modifikationer deraf
ATE266043T1 (de) Peptidanaloge des menschlichen basischen myelinproteins
DE69011853T2 (de) System zur bearbeitung von hefe, welches eine zur bearbeitungsstelle benachbarte negativ geladene aminosäure beeinhaltet.
DK0387231T3 (da) Hidtil ukendte inhibitorer for retroviral protease
ES2061956T3 (es) Procedimiento para la preparacion de peptidos retro-inversos y nuevos compuestos intermedios de los mismos.
PT99124A (pt) Processo para a preparacao de analogos de aprotinina e de composicoes farmaceuticas que os contem
EP0498784A3 (en) Inhibitors of retroviral protease
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
DE3364838D1 (en) Process for the conversion of preproinsulin analogues into insulins
ATE98963T1 (de) Somatotropinanaloge.
KR890008166A (ko) 융합 단백질의 선택적 분해 방법
EP0293130A3 (en) Dimers of parathyroid hormone antagonists
PT94011A (pt) Processo para a preparacao de 8 alfa- acilamino-ergolinas e de composicoes farmaceuticas que as contem
KR890700673A (ko) 돼지 성장호르몬 아날로그
AR247473A1 (es) Una composicion que produce una respuesta lactogenica o crecimiento en ganado bovino, excluidas todas sus aplicaciones terapeuticas
EA199900551A1 (ru) Фармацевтическая композиция, содержащая ингибитор иммуноглобулин-рецепторного взаимодействия
YU64192A (sh) Analozi insulina
PT89171A (pt) Processo de preparacao de compostos dipeptidos e de composicoes farmaceuticas que os contem
KR840007567A (ko) 펩티드의 제조방법

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19901011

FG3A Patent granted, date of granting

Effective date: 19961223

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20030630